C

Corbus Pharmaceuticals Holdings
D

CRBP

9.17000
USD
0.18
(2.00%)
مغلق
حجم التداول
8,228
الربح لكل سهم
-6
العائد الربحي
-
P/E
-2
حجم السوق
112,211,153
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
A
ACAD
0.190
(0.82%)
23.250 USD
ALNY
ALNY
1.29
(0.39%)
329.01 USD
A
AMRN
-0.070
(-0.45%)
15.450 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
I
INVA
-0.210
(-1.11%)
18.710 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
Z
ZYME
-0.680
(-4.86%)
13.320 USD
المزيد
الأخبار المقالات

العنوان: Corbus Pharmaceuticals Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.